Literature DB >> 1640955

The prevention and treatment of osteoporosis.

B L Riggs1, L J Melton.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1640955     DOI： 10.1056/NEJM199208273270908

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  101 in total

1.  Rheumatology: 15. Osteoporosis.

Authors:  J P Wade
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

2.  Bisphosphonate-associated femur fractures have high complication rates with operative fixation.

Authors:  Mark L Prasarn; Jaimo Ahn; David L Helfet; Joseph M Lane; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2012-06-06       Impact factor: 4.176

Review 3.  Postmenopausal hormone replacement therapy.

Authors:  H S Jacobs; F E Loeffler
Journal:  BMJ       Date:  1992-12-05

Review 4.  Overview of osteoporosis: pathophysiology and determinants of bone strength.

Authors:  Christopher M Bono; Thomas A Einhorn
Journal:  Eur Spine J       Date:  2003-09-12       Impact factor: 3.134

Review 5.  Reproductive aging and risk for chronic disease: Insights from studies of nonhuman primates.

Authors:  Susan E Appt; Kelly F Ethun
Journal:  Maturitas       Date:  2010-04-28       Impact factor: 4.342

6.  Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study.

Authors:  M Gambacciani; A Spinetti; F Taponeco; L Piaggesi; B Cappagli; M Ciaponi; L C Rovati; A R Genazzani
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

7.  Body size, estrogen use and thiazide diuretic use affect 5-year radial bone loss in postmenopausal women.

Authors:  M R Sowers; M K Clark; M L Jannausch; R B Wallace
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

8.  Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.

Authors:  J A Stakkestad; L I Benevolenskaya; J J Stepan; A Skag; A Nordby; E Oefjord; A Burdeska; I Jonkanski; P Mahoney
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin.

Authors:  S Adami; M C Baroni; M Broggini; L Carratelli; I Caruso; L Gnessi; M Laurenzi; A Lombardi; G Norbiato; S Ortolani
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

10.  Persistent mucosal damage and risk of fracture in celiac disease.

Authors:  Benjamin Lebwohl; Karl Michaëlsson; Peter H R Green; Jonas F Ludvigsson
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.